Last reviewed · How we verify
Ticagrelor- Immediate Administration — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Ticagrelor- Immediate Administration (Ticagrelor- Immediate Administration) — Massachusetts General Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ticagrelor- Immediate Administration TARGET | Ticagrelor- Immediate Administration | Massachusetts General Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ticagrelor- Immediate Administration CI watch — RSS
- Ticagrelor- Immediate Administration CI watch — Atom
- Ticagrelor- Immediate Administration CI watch — JSON
- Ticagrelor- Immediate Administration alone — RSS
Cite this brief
Drug Landscape (2026). Ticagrelor- Immediate Administration — Competitive Intelligence Brief. https://druglandscape.com/ci/ticagrelor-immediate-administration. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab